UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
<p><b>Abstract</b></p> <p><b>Background</b></p> <p>Pyoderma gangrenosum (PG) is a rare inflammatory skin disorder characterised by painful and rapidly progressing skin ulceration. PG can be extremely difficult to treat and patients often require...
Main Authors: | Craig Fiona F, Thomas Kim S, Mitchell Eleanor J, Williams Hywel C, Norrie John, Mason James M, Ormerod Anthony D |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://www.trialsjournal.com/content/13/1/51 |
Similar Items
-
Pyoderma gangrenosum: problems related to the diagnostics and treatment
by: A. V. Patrushev, et al.
Published: (2017-08-01) -
Pyoderma gangrenosum, diagnostic and therapeutic difficulties – two cases imitating breast cancer
by: Małgorzata Tupikowska, et al.
Published: (2016-02-01) -
Successful treatment with oral methylprednisolone and cyclosporine for refractory pyoderma gangrenosum in children: Report of a case and review of the literature
by: Xiaowen Huang, et al.
Published: (2020-03-01) -
A case with pyoderma gangrenosum, after an abdominal surgery
by: Gulbahar Sarac, et al.
Published: (2019-06-01) -
Pyoderma gangrenosum: An update
by: Ramesh M Bhat
Published: (2012-01-01)